US Stock MarketDetailed Quotes
VRCA Verrica Pharmaceuticals
- 1.110
- +0.119+12.01%
Close Nov 26 16:00 ET
- 1.150
- +0.040+3.59%
Post 19:48 ET
100.53MMarket Cap-603P/E (TTM)
1.150High0.970Low1.35MVolume0.983Open0.991Pre Close1.46MTurnover1.97%Turnover RatioLossP/E (Static)90.56MShares11.41052wk High-2.95P/B76.17MFloat Cap0.70452wk Low--Dividend TTM68.62MShs Float23.290Historical High--Div YieldTTM18.16%Amplitude0.704Historical Low1.075Avg Price1Lot Size
Verrica Pharmaceuticals Key Stats
EPS
According to the latest financial report of Verrica Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.49. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Verrica Pharmaceuticals's free cash flow? The latest report shows it as -8.57M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Verrica Pharmaceuticals shows that the company's current ratio is 1.34, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Verrica Pharmaceuticals, the quick ratio is 1.10, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Verrica Pharmaceuticals? The latest ROE figure is -191.16%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Verrica Pharmaceuticals, the total asset return on investment (ROA) is -53.83%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Verrica Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 124.42%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Verrica Pharmaceuticals, the net profit margin is 1.28K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data